Detalles de la búsqueda
1.
Understanding and addressing hepatitis C reinfection in the oral direct-acting antiviral era.
J Viral Hepat
; 25(3): 220-227, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29316030
2.
Directly observed therapy of sofosbuvir/ribavirin +/- peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT).
J Viral Hepat
; 25(1): 37-46, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28719029
3.
Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection.
J Viral Hepat
; 25(6): 631-639, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29274193
4.
Intrapatient viral diversity and treatment outcome in patients with genotype 3a hepatitis C virus infection on sofosbuvir-containing regimens.
J Viral Hepat
; 25(4): 344-353, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29112331
5.
Changes in Utilization and Discard of Hepatitis C-Infected Donor Livers in the Recent Era.
Am J Transplant
; 17(2): 519-527, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27456927
6.
Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin.
J Viral Hepat
; 24(4): 280-286, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27935166
7.
Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus.
J Viral Hepat
; 23(11): 857-865, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27291391
8.
Public health clinic-based hepatitis C testing and linkage to care in Baltimore.
J Viral Hepat
; 23(5): 366-74, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26840570
9.
Virological response rates for telaprevir-based hepatitis C triple therapy in patients with and without HIV coinfection.
HIV Med
; 15(2): 108-15, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24025147
10.
The new paradigm of hepatitis C therapy: integration of oral therapies into best practices.
J Viral Hepat
; 20(11): 745-60, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24168254
11.
Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C.
Mol Psychiatry
; 17(8): 781-9, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21691274
12.
Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.
J Viral Hepat
; 19(5): 332-40, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22497812
13.
Hip bone geometry in HIV/HCV-co-infected men and healthy controls.
Osteoporos Int
; 23(6): 1779-87, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21901477
14.
Hepatitis C treatment among racial and ethnic groups in the IDEAL trial.
J Viral Hepat
; 18(4): e134-43, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21108699
15.
Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population.
J Viral Hepat
; 17(2): 139-47, 2010 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19674282
16.
Potential role of chemerin in recruitment of plasmacytoid dendritic cells to diseased skin.
Biochem Biophys Res Commun
; 380(2): 323-7, 2009 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-19168032
17.
Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV-infected clinical cohort.
HIV Med
; 10(3): 133-42, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19207596
18.
Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis C.
J Viral Hepat
; 15(7): 475-81, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18363672
19.
All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET database.
Aliment Pharmacol Ther
; 45(1): 115-126, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27790729
20.
Primary Care Providers Knowledge, Attitude and Practices Related to Hepatitis C Screening and Treatment in the Oral Direct Acting Antiviral Agents Era.
J Community Med Health Educ
; 6(5)2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28083156